Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds

ClinAmygate430 enrolled

Overview

Comparing the incidence of SSI in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery

Comparing the incidence of surgical site infection (SSI) in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery. Also, comparing the post hospital stay.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Enrollment

430

Conditions

Surgical Site Infection Surgical Wound Surgical Wound Infection

Interventions

coated vicryl plusDRUG

Coated Polyglactin 910 with Triclosan (coated vicryl plus)

VicrylDRUG

Coated Polyglactin 910 without Triclosan (vicryl)

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * age: 18-75 * clean-contaminated wound surgery Exclusion Criteria: * Patient has immunodeficiency disorder. * Patient receiving anti-cancer / immunosuppressive therapy. * Patients with established pre-operative infection whether community acquired or hospital acquired either at / remote from the operative site.

Locations (1)

Misr Univeristy for Science and Technology Hospital

Giza, Egypt

RECRUITING

Outcomes

Primary Outcomes

Incidence of surgical site infection

Incidence of surgical site infection within 30 days

Time frame: 30 days

Secondary Outcomes

Hospital stay

duration of hospital stay

Time frame: 30 days

Central Contacts

Emad R Issak, Diploma

CONTACT

00201272228989 dr.emad.r.h.issak@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.